- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Semaglutide 2.4 mg and placebo 2.0 mg
Total 10827 results
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedObesitySpain, United States, France, Russian Federation, Canada, Colombia, South Africa, Norway, Denmark, Saudi Arabia, Sweden
-
Novo Nordisk A/SCompletedObesityKorea, Republic of, Thailand
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, India, Japan, Russian Federation, United Kingdom, Canada, Spain, South Africa, Germany, Greece, United Arab Emirates, Argentina, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompletedObesityUnited Kingdom, Canada, Denmark, Finland, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
PharmaMarApices Soluciones S.L.CompletedCOVID-19 InfectionSpain
-
AO GENERIUMRecruitingMetabolic Diseases | Mucopolysaccharidosis Type IIRussian Federation
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Dutch Heart FoundationRecruitingType 2 DiabetesNetherlands
-
Peptron, Inc.Active, not recruitingEarly Parkinson's DiseaseKorea, Republic of
-
Zuyderland Medisch CentrumNederlandse Obestias Kliniek (NOK)Not yet recruitingObesity | Obesity, Morbid | Weight Gain
-
Regado Biosciences, Inc.CompletedHealthy VolunteerUnited States
-
RemeGen Co., Ltd.Completed
-
Minerva NeurosciencesCompletedMajor Depressive DisorderUnited States, Bulgaria, Finland, Georgia, Moldova, Republic of, Poland, Ukraine
-
Cara Therapeutics, Inc.RecruitingPruritus | Notalgia ParestheticaUnited States, Poland, Spain, Canada, Germany
-
MacroGenicsActive, not recruitingMelanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditionsSpain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
-
Novo Nordisk A/SCompleted
-
Eisai Inc.BiogenActive, not recruitingAlzheimer's DiseaseUnited States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
-
Cara Therapeutics, Inc.CompletedPruritus | Notalgia ParestheticaUnited States, Canada
-
Bausch Health Americas, Inc.CompletedRheumatoid ArthritisUnited States
-
Santen Inc.CompletedAge-Related Macular DegenerationUnited States
-
Novo Nordisk A/SCompletedHealthy Volunteers (Diabetes Mellitus, Type 2)United Kingdom
-
Clementia Pharmaceuticals Inc.TerminatedExostoses, Multiple HereditaryUnited States, Spain, Canada, Japan, Italy, Portugal, United Kingdom, Turkey, Australia, Belgium, France, Netherlands
-
aTyr Pharma, Inc.Foundation for Sarcoidosis ResearchCompletedPulmonary SarcoidosisUnited States
-
Biozeus Biopharmaceutical S.A.Not yet recruitingFemale Sexual Dysfunction | Female Sexual Arousal Disorder
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
Eisai Inc.Completed
-
Novo Nordisk A/SCompletedOverweight and ObesityJapan, Korea, Republic of
-
ReveraGen BioPharma, Inc.University of Pittsburgh; Cooperative International Neuromuscular Research...CompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
ReveraGen BioPharma, Inc.National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
ReveraGen BioPharma, Inc.National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Sweden, Australia, Israel
-
McGill University Health Centre/Research Institute...Centre de Recherche du Centre Hospitalier de l'Université de Montréal; CIHR... and other collaboratorsTerminated
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Canada, Sweden, Latvia, Finland, Greece, Romania, Czechia, Puerto Rico
-
Kyowa Kirin Co., Ltd.Completed
-
Boehringer IngelheimCompleted
-
Oyster Point Pharma, Inc.CompletedDry Eye DiseaseUnited States
-
Maastricht University Medical CenterBayerCompletedCoronary Artery Disease | Coronary StenosisNetherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine
-
BioMarin PharmaceuticalTerminatedDuchenne Muscular DystrophyBelgium, Netherlands, France, United Kingdom, Italy
-
BayerMerck Sharp & Dohme LLC; Duke Clinical Research Institute; Canadian VIGOUR CentreCompletedChronic Heart Failure With Preserved Ejection FractionSpain, United States, Belgium, Singapore, Taiwan, Canada, Japan, Italy, Austria, Bulgaria, Germany, Greece, Israel, Poland, Portugal, Hungary, Russian Federation, Argentina, Colombia, Malaysia, South Africa
-
MedImmune LLCAmgenCompletedAsthmaUnited States, Slovakia, Israel, South Africa, Ukraine, Japan, Czechia, Hungary, Bulgaria, Serbia, Latvia, Lithuania
-
ConjuChemCompleted
-
Yuhan CorporationActive, not recruitingNon-Small Cell Lung CancerHungary, Korea, Republic of, Australia, Taiwan, Serbia, Singapore, Thailand, Philippines, Turkey, Malaysia, Russian Federation, Greece, Ukraine
-
Janssen Research & Development, LLCCompleted
-
Sansum Diabetes Research InstituteNovo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States